<DOC>
	<DOC>NCT00189800</DOC>
	<brief_summary>The purpose of this study is to ascertain the clinical results of solifenacin succinate of PIII study conducted in the original country using Korean patients with an overactive bladder.</brief_summary>
	<brief_title>A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Symptoms of overactive bladder Must be able to complete the micturition diary Pregnant or lactating Clinically significant outflow obstruction Significant post void residual urine Significant stress incontinence Urinary tract infection Chronic inflammation Bladder stones Previous pelvic radiation therapy Previous or current malignant disease of the pelvic organs Uncontrolled narrow angle glaucoma Urinary or gastric retention Electrostimulation therapy Bladder training Diabetic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>tolterodine</keyword>
	<keyword>randomized controlled trial</keyword>
	<keyword>double-blind method</keyword>
</DOC>